Impact of Comorbidities on Beneficial Effect of Lactated Ringers vs. Saline in Sepsis Patients

• Published in: Frontiers in medicine 2021-12, Vol.8, p.758902-758902
• Main Authors: Tseng, Chien-Hua, Chen, Tzu-Tao, Chan, Ming-Cheng, Chen, Kuan-Yuan, Wu, Sheng-Ming, Shih, Ming-Chieh, Tu, Yu-Kang
• Format: Article
• Language: English
• Subjects: fluid therapy; intensive care; lactated Ringers; Medicine; resuscitation; saline
• ISSN: 2296-858X; 2296-858X
• DOI: 10.3389/fmed.2021.758902

Lactated Ringers reduced mortality more than saline in sepsis patients but increased mortality more than saline in traumatic brain injury patients. This prospective cohort study was conducted in a medical intensive care unit (ICU) in central Taiwan. We applied standard sepsis evaluation protocol and identified heart, lung, liver, kidney, and endocrine comorbidities. We also evaluated resuscitation response with central venous pressure, central venous oxygen saturation, and serum lactate level simultaneously. Propensity-score matching and Cox regression were used to estimate mortality. The competing risk model compared the lengths of hospital stays with the subdistribution hazard ratio (SHR). Overall, 938 patients were included in the analysis. The lactated Ringers group had a lower mortality rate (adjusted hazard ratio, 0.59; 95% CI 0.43-0.81) and shorter lengths of hospital stay (SHR, 1.39; 95% C.I. 1.15-1.67) than the saline group; the differences were greater in patients with chronic pulmonary disease and small and non-significant in those with chronic kidney disease, moderate to severe liver disease and cerebral vascular disease. The resuscitation efficacy was the same between fluid types, but serum lactate levels were significantly higher in the lactated Ringers group than in the saline group (0.12 mg/dl/h; 95% C.I.: 0.03, 0.21), especially in chronic liver disease patients. Compared to the saline group, the lactated Ringers group achieved target glucose level earlier in both diabetes and non-diabetes patients. Lactate Ringer's solution provides greater benefits to patients with chronic pulmonary disease than to those with chronic kidney disease, or with moderate to severe liver disease. Comorbidities are important in choosing resuscitation fluid types.